- Home
- Publications
- Publication Search
- Publication Details
Title
Second-line chemotherapy for advanced gastric cancer in Korea
Authors
Keywords
-
Journal
Gastric Cancer
Volume 15, Issue 4, Pages 345-354
Publisher
Springer Nature
Online
2012-03-12
DOI
10.1007/s10120-011-0114-5
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- A Phase II Study of Irinotecan, Continuous 5-Fluorouracil, and Leucovorin (FOLFIRI) Combination Chemotherapy for Patients With Recurrent or Metastatic Gastric Cancer Previously Treated With a Fluoropyrimidine-Based Regimen
- (2010) Seok Hyun Kim et al. AMERICAN JOURNAL OF CLINICAL ONCOLOGY-CANCER CLINICAL TRIALS
- Phase II study of sunitinib as second-line treatment for advanced gastric cancer
- (2010) Yung-Jue Bang et al. INVESTIGATIONAL NEW DRUGS
- Trastuzumab in combination with chemotherapy versus chemotherapy alone for treatment of HER2-positive advanced gastric or gastro-oesophageal junction cancer (ToGA): a phase 3, open-label, randomised controlled trial
- (2010) Yung-Jue Bang et al. LANCET
- Irinotecan plus S-1 (IRIS) versus fluorouracil and folinic acid plus irinotecan (FOLFIRI) as second-line chemotherapy for metastatic colorectal cancer: a randomised phase 2/3 non-inferiority study (FIRIS study)
- (2010) Kei Muro et al. LANCET ONCOLOGY
- Mitomycin C plus S-1 as second-line therapy in patients with advanced gastric cancer: a noncomparative phase II study
- (2009) Se Hoon Park et al. ANTI-CANCER DRUGS
- A retrospective analysis of second-line chemotherapy in patients with advanced gastric cancer
- (2009) Sang Hoon Ji et al. BMC CANCER
- Phase II study of S-1 monotherapy in paclitaxel- and cisplatin-refractory gastric cancer
- (2009) Sung-Ji Lee et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Docetaxel: its role in current and future treatments for advanced gastric cancer
- (2009) Masahiko Nishiyama et al. Gastric Cancer
- Paclitaxel chemotherapy for the treatment of gastric cancer
- (2009) Junichi Sakamoto et al. Gastric Cancer
- Second-line Chemotherapy with Biweekly Paclitaxel after Failure of Fluoropyrimidine-based Treatment in Patients with Advanced or Recurrent Gastric Cancer: a Report from the Gastrointestinal Oncology Group of the Tokyo Cooperative Oncology Group, TCOG GC-0501 Trial
- (2009) W. Koizumi et al. JAPANESE JOURNAL OF CLINICAL ONCOLOGY
- Is there a role for second-line chemotherapy in advanced gastric cancer?
- (2009) Robert Wesolowski et al. LANCET ONCOLOGY
- A Phase II Feasibility Study of Weekly Paclitaxel in Heavily Pretreated Advanced Gastric Cancer Patients with Poor Performance Status
- (2009) Chong Kun Im et al. ONCOLOGY
- Phase II study of combination chemotherapy of 5-fluorouracil, low-dose leucovorin, and oxaliplatin (FLOX regimen) in pretreated advanced gastric cancer
- (2008) J. Jeong et al. ANNALS OF ONCOLOGY
- A phase II study of irinotecan and docetaxel combination chemotherapy for patients with previously treated metastatic or recurrent advanced gastric cancer
- (2008) Sun Jin Sym et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Chemotherapy for metastatic gastric cancer: past, present, and future
- (2008) Atsushi Ohtsu JOURNAL OF GASTROENTEROLOGY
- Changing trends in the proportion of adenocarcinoma of the esophagogastric junction in a large tertiary referral center in Japan
- (2008) Chika Kusano et al. JOURNAL OF GASTROENTEROLOGY AND HEPATOLOGY
- S-1 plus cisplatin versus S-1 alone for first-line treatment of advanced gastric cancer (SPIRITS trial): a phase III trial
- (2008) Wasaburo Koizumi et al. LANCET ONCOLOGY
Find the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
SearchCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now